DYMELOR Drug Patent Profile
✉ Email this page to a colleague
When do Dymelor patents expire, and what generic alternatives are available?
Dymelor is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in DYMELOR is acetohexamide. There are six drug master file entries for this compound. Additional details are available on the acetohexamide profile page.
Summary for DYMELOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Clinical Trials: | 1 |
Patent Applications: | 3,882 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DYMELOR at DailyMed |
Recent Clinical Trials for DYMELOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Novartis | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for DYMELOR
US Patents and Regulatory Information for DYMELOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | DYMELOR | acetohexamide | TABLET;ORAL | 013378-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | DYMELOR | acetohexamide | TABLET;ORAL | 013378-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |